Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Erythropoietin Stimulating Agents Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of HIV, cancer, and ESRD globally
5.1.1.2. Increasing development of synthetic forms of ESRD with enhanced recombinant DNA technology
5.1.1.3. Favorable government initiatives to increase healthcare infrastructures
5.1.2. Restraints
5.1.2.1. High cost EPO drugs
5.1.3. Opportunities
5.1.3.1. Introduction of novel drugs and cost-efficient biosimilar formulations
5.1.3.2. Ongoing robust research and development activities to develop innovative molecules
5.1.4. Challenges
5.1.4.1. Stringent regulatory protocols for drug approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Erythropoietin Stimulating Agents Market, by Type
6.1. Introduction
6.2. Darbepoetin Alfa
6.3. Epoetin Alfa
6.4. Epoetin Beta
6.5. Epoetin-Delta
6.6. Epoetin-Omega

7. Erythropoietin Stimulating Agents Market, by Application
7.1. Introduction
7.2. Anemia
7.3. Antiretroviral Treatment
7.4. Cancer Chemotherapy
7.5. Kidney Disorders
7.6. Neural Disease
7.7. Oncology Diseases
7.8. Wound Healing

8. Americas Erythropoietin Stimulating Agents Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Erythropoietin Stimulating Agents Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Erythropoietin Stimulating Agents Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Amgen Inc.
12.1.2. Biocon Limited
12.1.3. Celltrion, Inc.
12.1.4. Cipla Limited
12.1.5. Dr. Reddys Laboratories Ltd.
12.1.6. F. Hoffmann-La Roche Ltd.
12.1.7. Intas Pharmaceuticals Limited
12.1.8. Johnson & Johnson
12.1.9. Kyowa Kirin Co., Ltd.
12.1.10. LG Life Sciences Ltd.
12.1.11. Pfizer Inc.
12.1.12. Sun Pharmaceutical Industries Ltd.
12.1.13. Teva Pharmaceutical Industries Ltd.
12.1.14. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. ERYTHROPOIETIN STIMULATING AGENTS MARKET RESEARCH PROCESS
FIGURE 2. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ERYTHROPOIETIN STIMULATING AGENTS MARKET DYNAMICS
FIGURE 7. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ERYTHROPOIETIN STIMULATING AGENTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ERYTHROPOIETIN STIMULATING AGENTS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ERYTHROPOIETIN STIMULATING AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY EPOETIN BETA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY EPOETIN-DELTA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY EPOETIN-OMEGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY ANTIRETROVIRAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY CANCER CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY KIDNEY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY NEURAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY ONCOLOGY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. MEXICO ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AUSTRALIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CHINA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CHINA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. INDIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. INDIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. INDONESIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. JAPAN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. JAPAN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MALAYSIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. PHILIPPINES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. SINGAPORE ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. SOUTH KOREA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. TAIWAN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. THAILAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. THAILAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. VIETNAM ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. DENMARK ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. DENMARK ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. EGYPT ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. EGYPT ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. FINLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. FINLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. FRANCE ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. FRANCE ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. GERMANY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. ISRAEL ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ITALY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. ITALY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. NETHERLANDS ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. NIGERIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. NORWAY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. NORWAY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. POLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. POLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. QATAR ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. QATAR ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. RUSSIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SPAIN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SPAIN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. SWEDEN ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SWITZERLAND ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. TURKEY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. TURKEY ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ERYTHROPOIETIN STIMULATING AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. ERYTHROPOIETIN STIMULATING AGENTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 106. ERYTHROPOIETIN STIMULATING AGENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 107. ERYTHROPOIETIN STIMULATING AGENTS MARKET LICENSE & PRICING